Related Experiment Video
Updated: Jan 21, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
ORC-13661 protects sensory hair cells from aminoglycoside and cisplatin ototoxicity
Siân R Kitcher1, Nerissa K Kirkwood1, Esra D Camci2
1Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom.
Abstract:
Aminoglycoside (AG) antibiotics are widely used to prevent life-threatening infections, and cisplatin is used in the treatment of various cancers, but both are ototoxic and result in loss of sensory hair cells from the inner ear. ORC-13661 is a new drug that was derived from PROTO-1, a compound first identified as protective in a large-scale screen utilizing hair cells in the lateral line organs of zebrafish larvae. Here, we demonstrate, in zebrafish larvae and in mouse cochlear cultures, that ORC-13661 provides robust protection of hair cells against both ototoxins, the AGs and cisplatin. ORC-13661 also prevents both hearing loss in a dose-dependent manner in rats treated with amikacin and the loading of neomycin-Texas Red into lateral line hair cells. In addition, patch-clamp recordings in mouse cochlear cultures reveal that ORC-13661 is a high-affinity permeant blocker of the mechanoelectrical transducer (MET) channel in outer hair cells, suggesting that it may reduce the toxicity of AGs by directly competing for entry at the level of the MET channel and of cisplatin by a MET-dependent mechanism. ORC-13661 is therefore a promising and versatile protectant that reversibly blocks the hair cell MET channel and operates across multiple species and toxins.
Insights
A new drug, ORC-13661, protects inner ear sensory hair cells from damage caused by common antibiotics and chemotherapy drugs. This discovery offers hope for preventing drug-induced hearing loss and ototoxicity.
Area of Science:
- Ototoxicity research
- Drug discovery
- Hair cell biology
Background:
- Aminoglycoside antibiotics and cisplatin are ototoxic, causing sensory hair cell loss and hearing impairment.
- Current treatments lack effective methods to prevent drug-induced ototoxicity.
Purpose of the Study:
- To evaluate ORC-13661 as a protectant against ototoxicity from aminoglycosides and cisplatin.
- To elucidate the mechanism of action for ORC-13661 in preventing hair cell damage.
Main Methods:
- Utilized zebrafish larvae and mouse cochlear cultures to test ORC-13661 efficacy.
- Administered amikacin to rats to assess hearing loss prevention.
- Performed patch-clamp recordings to analyze ORC-13661 interaction with mechanoelectrical transducer (MET) channels.
Main Results:
- ORC-13661 demonstrated robust protection of hair cells against both aminoglycosides and cisplatin in vitro and in vivo.
- ORC-13661 dose-dependently prevented amikacin-induced hearing loss in rats.
- ORC-13661 acts as a high-affinity blocker of the hair cell MET channel, suggesting a protective mechanism.
Conclusions:
- ORC-13661 is a versatile and promising compound for preventing ototoxicity.
- The drug's ability to block the MET channel offers a novel strategy against drug-induced hearing loss.
- ORC-13661 shows potential for cross-species and broad-spectrum ototoxin protection.
Related Concept Videos
Hair Cells
Estimation of k and VD of Aminoglycosides
What is a Sensory System?
Accessory Structures of the Skin: Hair and Hair Follicles
Hair is a keratinous filament growing out of the epidermis. It is primarily made of dead, keratinized cells. Hair strands originate at the epidermal penetration called the hair follicle. The hair shaft is the part...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...

